Oracle Unveils Oracle® Health Sciences Cloud

OracleOracle announced that its portfolio of Oracle Health Sciences Cloud Applications will be powered by the next-generation Oracle® Health Sciences Cloud, a scalable and secure software-as-a-service delivery platform tailored for the specific requirements and regulations of the health sciences market.

The enhanced Oracle Health Sciences Cloud delivers life sciences and healthcare applications with unparalleled performance, scalability and security. It supports the increasingly networked environment for research, clinical development, and healthcare delivery wherein data must be effectively and securely managed across multiple organizations, including life sciences companies, contract research organizations (CROs), academic medical centers, and regulators and outsourcing vendors.

In conjunction with Oracle Health Sciences Cloud Applications, Oracle Health Sciences Cloud will help health sciences organizations further accelerate IT deployments, reduce resources required to maintain IT infrastructure and gain a more predictable IT spending pattern. Oracle Health Sciences Cloud is developed and rigorously tested for the specific security and privacy requirements of the health sciences industry. This HIPAA certified cloud provides full qualification and validation testing for each instance of the deployed application and is compliant with U.S. Food & Drug Administration (FDA) 21 CFR Part 11.

Oracle Health Sciences solutions currently available as a service on the Oracle Health Sciences Cloud include electronic data capture, electronic patient reported outcomes, study design, coding and dictionary management, trial randomization and drug supply management, research clinic automation, as well as safety management and will expand over time. The Oracle Health Sciences Cloud currently hosts over 3,800 application instances supporting hundreds of thousands of users and millions of transactions per day in more than 117 countries.

The new Oracle Health Sciences Cloud will take advantage of Oracle’s hardware and software, including Oracle Fusion Middleware, Oracle Exadata Database Machine, and Oracle’s Sun ZFS Storage Appliance.

"Delivering cloud applications that support the stringent regulatory environment and networked nature of clinical trials requires not only technical expertise, but significant industry expertise, as well," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Oracle Health Sciences Cloud and our proven portfolio of Oracle Health Sciences Cloud Applications offer customers a formidable combination of scalability, data security, value, and confidence."

Related news articles:

About Oracle
Oracle is the world's most complete, open, and integrated business software and hardware systems company. For more information about Oracle, please visit http://www.oracle.com.

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...